Literature DB >> 11257658

The Willet F. Whitmore, Jr., Lectureship: blockade of epidermal growth factor receptors as anticancer therapy.

J Mendelsohn1, C P Dinney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257658

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

Review 1.  An update on epidermal growth factor receptor inhibitors.

Authors:  Shanu Modi; Andrew D Seidman
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.

Authors:  Ramaswamy Bhuvaneswari; Yik Yuen Gan; Khee Chee Soo; Malini Olivo
Journal:  Mol Cancer       Date:  2009-11-02       Impact factor: 27.401

3.  Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?

Authors:  Wassim Kassouf; Gordon A Brown; Peter C Black; Mark B Fisher; Teruo Inamoto; Tony Luongo; David Gallagher; Menashe Bar-Eli; David J McConkey; Liana Adam; Colin P N Dinney
Journal:  J Urol       Date:  2008-07-18       Impact factor: 7.450

4.  Targeted therapies in the management of metastatic bladder cancer.

Authors:  Matteo Fassan; Edouard J Trabulsi; Leonard G Gomella; Raffaele Baffa
Journal:  Biologics       Date:  2007-12

5.  A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer.

Authors:  Jose Joao Mansure; Roland Nassim; Simone Chevalier; Konrad Szymanski; Joice Rocha; Saad Aldousari; Wassim Kassouf
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.